Considered as an oral antineoplastic agent, Imatinib Tablets IP 400 mg help in treating specific cancers such as CML and gastrointestinal stromal tumors. These agents fall within kinases called tyrosine kinase inhibitors (TKIs) and hence aim to inhibit the specific enzyme causing uncontrolled proliferation of cancer cells.
How Does Imatinib Work Against Cancer?
Imatinib inhibits abnormal proteins that promote cancer growth. Hence, unlike cytotoxic chemotherapy, which targets all kinds of cells that undergo rapid division, Imatinib Tablets IP 400 mg work in a far more selective manner. This targeted action lessens damage to formerly healthy tissues, thus enabling more tolerable cancer treatment and greater chances of patient survival in the long run.
When and How to Use
The Imatinib Tablets IP 400 mg are generally prescribed when long-term therapy is intended. Dosing varies with age, body weight, type and stage of cancer, and also the patient's prior medical history. It is mostly taken once or twice daily with food to reduce side effects related to the GI tract. Hence, taking this medicine consistently is vital for achieving a favorable outcome in cancer therapy.
Common Side Effects
Usually well tolerated, Imatinib Tablets IP 400 mg, however, may cause side effects in some individuals. These include nausea, muscle cramps, fatigue, and mild fluid retention. It warrants regular checkups with blood tests for side effects and efficacy of therapy.
Ending Notes
In some respects, Imatinib Tablets IP 400 mg are at the forefront of modern targeted cancer therapy. Targeted cancer drugs like Imatinib somewhat offer anti-tumor activities with fewer side effects. Under the care of consultants, Imatinib gives all patients life to live and a successful outcome.
Comments
0 comment